2013 Prevention Guidelines

What's a Clinician to Do? Implementation of the 2013 Prevention Guidelines

Dr. Donald Lloyd-Jones, thought leader who played a major role in the development of the 2013 risk assessment and prevention guidelines, takes the learner through a case-based approach in the clinical application of the guidelines.

Credit: .92 (0.5 Pharmacology)
Cost: Free

Take this Course

Faculty
  •  Donald Lloyd-Jones, MD/ScM
Upon completion, participants will be able to:
  • Describe process for assessing appropriateness for statin therapy in the high risk primary prevention patient
  • Describe steps in the addition of non-statin therapy to the treatment regimen of a patient with residual risk.
Lipid Profile Test
This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is accredited by the American Association of Nurse Practitioners (AANP) as an approved provider of Nurse Practitioner continuing education, provider number 030602.